The DOI matches its Crossref record.
Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
Abstract
Recent meta-analyses have revealed that the risk of bone fracture is increased in both type 1 and type 2 diabetic patients. Low bone mineral density (BMD) can not necessarily explain the link, because BMD is increased rather than decreased in type 2 diabetes, while it is consistently low in type 1 diabetes subjects. Although multiple factors could influence the quality of bone and increase the bone fragility in diabetes, there is accumulating evidence for the association between osteoporosis and vascular calcification, which is an independent predictor of cardiovascular disease morbidity and mortality. Advanced glycation end products (AGEs) are formed by a non-enzymatic reaction between aldehydes of reducing sugars and the amino groups of proteins, lipids and nucleic acids that could contribute to the aging of macromolecules. The formation and accumulation of AGEs have been known to progress at an accelerated rate under diabetes. There is a growing body of evidence that AGEs and their receptor (RAGE) system elicit oxidative stress generation and subsequently evoke inflammatory responses in vascular wall cells, osteoblasts and osteoclasts, thereby being involved in both vascular calcification and osteoporosis in diabetes. Further, cross-linking in the organic bone matrix by AGEs could adversely affect the fracture resistance of bone. Therefore, in this paper, I review the pathophysiological role of the AGEs-RAGE-oxidative stress system in decreased BMD and increased bone fragility in diabetes. I also discuss here the potential therapeutic interventions of the AGEs-RAGE axis for preventing osteoporosis in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chaudhuri, J., Bains, Y., Guha, S., Kahn, A., Hall, D., Bose, N., Gugliucci, A., & Kapahi, P. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.014 · Cited by 669
“Similar work has underscored the importance of AGEs in bone health with age (Yamagishi, 2011).”
BackgroundDiabetes and Its Effect on Bone and Fracture Healing
Jiao, H., Xiao, E., & Graves, D. T. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0286-8 · Cited by 522
Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures
Patsch, J. M., Burghardt, A. J., Yap, S. P., Baum, T., Schwartz, A. V., Joseph, G. B., & Link, T. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1763 · Cited by 436
Ma, H., Wang, X., Zhang, W., Li, H., Zhao, W., Sun, J., & Yang, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9067610 · Cited by 392
GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
Mori, Y., Matsui, T., Hirano, T., & Yamagishi, S.-I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041509 · Cited by 60
Self-citation
Metadata
- Authors
- Yamagishi, S.-I.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-12-01
- Volume
- 12
- Issue
- 14
- Pages
- 2096-2102
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2018294401
- Cited by
- 164
- References
- 0
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes. https://app.cochat.ai/papers/10.2174/138945011798829456
- The paper
- Yamagishi, S.-I. (2011). Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes. Current Drug Targets. https://doi.org/10.2174/138945011798829456
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.